Morschhauser, Franck <br/><br/>
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.  [electronic resource] 

 -  Molecular cancer therapeutics  02 2020 
 - 468-478 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-19-0466  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biopsy--methods<br/>Cell Line, Tumor<br/>Female<br/>Humans<br/>Lymphoma--drug therapy<br/>Male<br/>Neoplasms--drug therapy<br/>Phosphatidylinositol 3-Kinases--pharmacology<br/>Pyrimidines--pharmacology<br/>Quinazolines--pharmacology